Mifloksan Adverse Reactions

Concise Prescribing Info Bahasa Concise Prescribing Info Full Prescribing Info Contents Description Action Indications/Uses Dosage/Direction for Use Overdosage Contraindications Special Precautions Use In Pregnancy & Lactation Adverse Reactions Drug Interactions Storage MIMS Class ATC Classification Regulatory Classification Presentation/Packing

Full Prescribing Info

Adverse Reactions

Nonocular adverse events were fever, increasing cough, infection, otitis media, pharyngitis, rash, and rhinitis.
The following adverse reactions are related to treatment (monotherapy with MIFLOKSAN ophthalmic solution) and classified according to the following convention: Very common (≥1/10), common (≥1/100 to <1/10), uncommon (>1/1,000 to ≤1/100), rare (>1/10,000 to ≤1/1,000), or very rare (≤1/10,000). Within each frequency grouping, adverse reactions are presented in decreasing order of seriousness. (See Table 1.)

Click on icon to see table/diagram/image

Adverse events identified from the post-marketing experience are as follows. The frequency of adverse events cannot be estimated from the existing data. Within each frequency grouping, adverse reactions are presented in decreasing order of seriousness. (See Table 2.)

Click on icon to see table/diagram/image

View ADR Reporting Link

Mifloksan Adverse Reactions

moxifloxacin

Manufacturer:

Sanbe

Marketer:

Sanbe